Rafael Esteban
Overview
Explore the profile of Rafael Esteban including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
203
Citations
4058
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Albertos S, Majo F, Esteban R, Colom J, Buti M
Front Public Health
. 2024 Dec;
12:1478195.
PMID: 39717035
Aim: To assess the feasibility and acceptability of massive hepatitis C virus (HCV) testing in point of care on the street using quick tests, determine the characteristics of the population...
2.
Buti M, Ruiz-Cobo J, Esteban R, Riveiro-Barciela M
Clin Mol Hepatol
. 2024 Nov;
PMID: 39523715
Acute hepatitis E virus (HEV) infection is typically self-limiting and has a favourable prognosis. However, certain populations such as patients with pre-existing chronic liver disease may experience severe manifestations, including...
3.
Vargas-Accarino E, Rando-Segura A, Palom A, Feliu-Prius A, Martinez-Camprecios J, Barreira A, et al.
Aliment Pharmacol Ther
. 2024 Aug;
60(10):1308-1314.
PMID: 39192590
Background: The WHO has set a goal to decrease viral hepatitis-related fatalities by 65% by 2030. Aims: To locate and retrieve to care all individuals diagnosed with hepatitis B, D...
4.
Esteban R, Dominguez-Hernandez R, Cantero H, Casado M
Gastroenterol Hepatol
. 2024 May;
47(10):502199.
PMID: 38723771
Objective: Direct-acting antivirals for the treatment of hepatitis C virus (HCV) represented a paradigm shift. In 2017, sofosbuvir/velpatasvir (SOF/VEL-Epclusa®) was approved, which showed a high cure rate in all patient,...
5.
Buti M, Vaz-Pinto I, Pereira V, Casado M, Llaneras J, Barreira A, et al.
Int J Emerg Med
. 2024 Jan;
17(1):5.
PMID: 38178000
Background: Undiagnosed cases of hepatitis C virus (HCV) infection result in significant morbidity and mortality, further transmission, and increased public health costs. Testing in emergency departments (EDs) is an opportunity...
6.
Feliu-Prius A, Barreira-Diaz A, Rando A, Vargas-Accarino E, Palom A, Vico-Romero J, et al.
Liver Int
. 2023 Dec;
44(3):706-714.
PMID: 38111084
Background & Aims: Hepatitis B infection is the most frequent cause of chronic hepatitis and liver cancer worldwide. Active searching for individuals with chronic hepatitis B has been proposed as...
7.
Llaneras J, Ruiz-Cobo J, Rando-Segura A, Barreira-Diaz A, Dominguez-Hernandez R, Rodriguez-Frias F, et al.
JHEP Rep
. 2023 Dec;
6(1):100932.
PMID: 38074506
Background & Aims: Many people with HCV and HBV infection are unaware of their condition, particularly at-risk and vulnerable populations who face barriers for screening and linkage to care. Emergency...
8.
Buti M, Dominguez-Hernandez R, Palom A, Esteban R, Casado M
Liver Int
. 2023 Nov;
43(12):2611-2614.
PMID: 37916574
Chronic hepatitis D (CHD) is a severe form of viral hepatitis that leads to liver cirrhosis and hepatocellular carcinoma. CHD is underdiagnosed, and this study aimed to assess the impact...
9.
Roade L, Riveiro-Barciela M, Pfefferkorn M, Sopena S, Palom A, Bes M, et al.
JHEP Rep
. 2023 Sep;
5(10):100842.
PMID: 37745192
Background & Aims: HBsAg proteins are useful to identify HBV inactive carriers (ICs), but data on chronic hepatitis D (CHD) are scarce. This study aimed to describe HBsAg composition in...
10.
Riveiro-Barciela M, Roade L, Martinez-Camprecios J, Vidal-Gonzalez J, Rodriguez-Diez B, Perello M, et al.
Gastroenterol Hepatol
. 2023 Feb;
46(10):764-773.
PMID: 36731726
Background: Chronic hepatitis E virus (HEV) in persons with immune impairment has a progressive course leading to a rapid progression to liver cirrhosis. However, prospective data on chronic HEV is...